#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience


Authors: Alessandra Mangia;  Valeria Piazzolla;  Anna Giannelli;  Egidio Visaggi;  Nicola Minerva;  Vincenzo Palmieri;  Immacolata Carraturo;  Domenico Potenza;  Nicola Napoli;  Gianfranco Lauletta;  Vincenzo Tagarielli;  Rosanna Santoro;  Ernesto Piccigallo;  Sergio De Gioia;  Angelo Chimenti;  Giuseppe Cuccorese;  Antonio Metrangolo;  Michele Mazzola;  Ernesto Agostinacchio;  Giuseppe Mennea;  Carlo Sabbà;  Marina Cela;  Massimiliano Copetti;  Ruggiero Losappio
Published in the journal: PLoS ONE 14(9)
Category: Correction
doi: https://doi.org/10.1371/journal.pone.0223287

In the SVR, co-morbidities and concomitant medication subsection of the Results, there is an error in the 15th sentence of the first paragraph. The correct sentence is: Among PWID, 35% of patients were taking different antipsychotics or anesthetics to treat chronic pain as analgesics (10 olanzepine, 15 haloperidol and 21 ketamine).


Zdroje

1. Mangia A, Piazzolla V, Giannelli A, Visaggi E, Minerva N, Palmieri V, et al. (2019) SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience. PLoS ONE 14(5): e0215783. https://doi.org/10.1371/journal.pone.0215783 31091254


Článok vyšiel v časopise

PLOS One


2019 Číslo 9
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#